Pharmaceuticals
EU lifts ban on Ranbaxy’s Toansa-made drugs
06 Jun 2014
European regulators on Thursday lifted the EU ban on drugs manufactured at Ranbaxy Laboratories' Toansa plant, saying they do not pose a risk to public health
US FDA gives `fast-track’ status for AstraZeneca’s novel antibiotic for treatment of gonorrhea
04 Jun 2014
FDA hits Wockhardt again; this time over Illinois plant
04 Jun 2014
Wockhardt again faces strictures from the US FDA – this time over its facility in Chicago in Illinois
Stryker denies Smith & Nephew bid
29 May 2014
Valeant raises Allergan bid to $49.44 bn: analysts say new offer still too low
29 May 2014
A successful deal with Allergan would more than double the size of Valeant and make it one of the largest specialty pharmaceutical companies in the world
